Market Overview
According to IMARC Group's latest research publication, " Ophthalmic Lasers Market Report by Product (Diode Lasers, Femtosecond Lasers, Excimer Lasers, Nd: YAG Lasers, SLT Lasers, and Others), Indication (Glaucoma, Cataract Removal, Refractive Error Corrections, Diabetic Retinopathy, and Others), End-User (Hospitals, Eye Clinics, and Others), and Region 2026-2034 ", the global ophthalmic lasers market size reached USD 1.4 Billion in 2025. Looking ahead, IMARC Group expects the market to reach USD 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.10% during 2026-2034 , with the industry witnessing steady expansion. North America currently dominates the market, driven by the rise in the adoption of highly advanced techniques and systems in the manufacturing of ophthalmic lasers, alongside rising cases of eye disorders in the region.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
How Femtosecond Technology is Reshaping the Future of the Ophthalmic Lasers Market
Increasing demand for minimally invasive procedures, growing adoption of femtosecond lasers for cataract surgery, and rising prevalence of ophthalmic disorders are key factors driving market growth.
The increasing prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy, coupled with an aging population worldwide, is increasing the demand for ophthalmic laser procedures.
Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions.
New laser systems with improved targeting capabilities and reduced side effects are expanding treatment options for ophthalmologists, leading to increased demand in both surgical and therapeutic applications.
The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorders, is catalyzing growth.
Grab a sample copy of this report: https://www.imarcgroup.com/ophthalmic-lasers-market/requestsample
Key Trends in the Ophthalmic Lasers Market
Increasing Prevalence of Eye Disorders: The increasing cases of vision-related disorders are primarily driving the growth of the market. According to the WHO, at least 2.2 billion people had near or distant vision impairment across the globe, and vision impairment poses a global financial burden associated with uncorrected myopia and presbyopia. A press release by the World Economic Forum indicated that rates of short-sightedness (myopia) rose significantly, and it's predicted that half of the world's population will be short-sighted. Approximately 88.4 million people suffered blindness due to unaddressed refractive errors. Besides this, the rising geriatric population across the globe, who are more prone to developing eye disorders, is further catalyzing market demand. There are currently roughly 62 million adults aged 65 and older living in the U.S., accounting for 18% of the population. By 2054, 84 million adults aged 65 and older will make up an estimated 23% of the population.
Technological Advancements: Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions. Moreover, the increasing adoption of femtosecond laser technology for precise and minimally invasive procedures such as LASIK, cataract surgery, and corneal transplantation is offering lucrative growth opportunities. Various key market players are launching ophthalmic lasers with advanced technologies for enhanced diagnostics, treatment planning, and personalized patient care. For instance, in April 2022, Nova Eye Medical launched its next-generation canaloplasty device, iTrack Advance, in Europe and Asia-Pacific. The iTrack Advance features include a proprietary illuminated fiber optic tip of the original iTrack device to allow the surgeon to continuously monitor the location of the device in Schlemm's canal. Similarly, Lumibird Group launched the Capsulo Nd: YAG laser, designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments.
Expanding Product Application Beyond Traditional Vision Correction: The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorders such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion, is also catalyzing the growth of the global market. In diabetic retinopathy, laser photocoagulation is commonly used to seal leaking blood vessels or to destroy abnormal blood vessels that may be causing vision loss. According to IMARC, the global diabetic retinopathy market size reached US8.1Billion∗∗.Lookingforward,IMARCGroupexpectsthemarkettoreach∗∗US 13.0 Billion, exhibiting a growth rate of 5.2%. Similarly, the escalating utilization of ophthalmic lasers in AMD to target and seal abnormal blood vessels, reducing the risk of further vision deterioration, is also contributing to the market growth. According to a research article published in the British Journal of Ophthalmology, in Europe, age-related macular degeneration is the main cause of visual impairment and blindness. About 67 million people in Europe are affected by AMD. As per the market forecast, the increasing number of individuals with retinal disorders is directly proportional to market growth.
Rising Geriatric Population: The rising geriatric population across the globe, who are more prone to developing eye disorders, is further catalyzing market demand. By 2054, 84 million adults aged 65 and older will make up an estimated 23% of the population. This demographic shift is creating sustained demand for ophthalmic laser procedures across surgical and therapeutic applications.
Growing Adoption of Femtosecond Lasers: Femtosecond lasers account for the majority of the global market share. These ultrafast laser systems emit pulses lasting femtoseconds and find extensive use in ophthalmology for LASIK surgery, where they precisely reshape corneal tissue, leading to improved vision correction outcomes. Their unique properties, including high peak power and ultrashort pulses, make them indispensable tools across diverse applications.
Growth Factors in the Ophthalmic Lasers Market
Increasing Prevalence of Eye Disorders: The increasing prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy, coupled with an aging population worldwide, is augmenting the demand for ophthalmic laser procedures. Furthermore, the rising geriatric population, who are more prone to developing such conditions, is also contributing to market growth. The increasing cases of vision-related disorders are primarily driving the growth of the market.
Rising Adoption of Minimally Invasive Procedures: Increasing demand for minimally invasive procedures is a key factor driving market growth. The growing adoption of femtosecond lasers for cataract surgery offers precise and minimally invasive treatment options, expanding treatment options for ophthalmologists.
Technological Advancements in Laser Systems: Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions. New laser systems with improved targeting capabilities and reduced side effects are expanding treatment options for ophthalmologists, leading to increased demand in both surgical and therapeutic applications.
Expanding Applications in Retinal Disorders: The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorders such as diabetic retinopathy and age-related macular degeneration, is catalyzing market growth. In diabetic retinopathy, laser photocoagulation is commonly used to seal leaking blood vessels or destroy abnormal blood vessels that may be causing vision loss.
Expedited Regulatory Approvals: Regulatory authorities are expediting the approval process for laser technologies, creating a positive outlook for the market. For instance, LASEROPTEK Co., Ltd. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PicoLO Premium picosecond pulse Nd: YAG laser. The approvals of such innovative products in the United States are positively impacting the market outlook.
Leading Companies Operating in the Global Ophthalmic Lasers Industry
Alcon Laboratories Inc. (Novartis AG)
Johnson & Johnson Surgical Vision Inc.
Bausch + Lomb
Ellex Medical Lasers Limited
IRIDEX Corporation
Lumenis
Topcon
A.R.C. Laser
Abbott Medical Optics
Calmar Laser
Carl Zeiss Meditec
Meridian
Nidek
Optos
Quantel
Ziemer
Ophthalmic Lasers Market Report Segmentation
Breakup By Product
Diode Lasers
Femtosecond Lasers
Excimer Lasers
Nd: YAG Lasers
SLT Lasers
Others
Femtosecond lasers account for the majority of the global market share. Femtosecond lasers are ultrafast laser systems that emit pulses lasting femtoseconds (10^-15 seconds). They find extensive use in various fields, such as ophthalmology for LASIK surgery, where they precisely reshape corneal tissue, leading to improved vision correction outcomes. Furthermore, femtosecond lasers are pivotal in scientific research, facilitating studies on ultrafast phenomena, such as molecular dynamics and quantum interactions. Their unique properties, including high peak power and ultrashort pulses, make them indispensable tools across diverse applications, promising advancements in medicine, technology, and fundamental science.
Breakup By Indication
Glaucoma
Cataract Removal
Refractive Error Corrections
Diabetic Retinopathy
Others
Refractive error corrections currently exhibit a clear dominance in the market. Ophthalmic lasers play a crucial role in correcting refractive errors, such as myopia, hyperopia, and astigmatism. In procedures like LASIK and PRK, these lasers reshape the cornea to adjust its focusing power, thereby improving vision. An article published in the Journal of Annals of Medicine and Surgery indicated that refractive errors are the most common vision problem and prove to be a significant health issue. Similarly, according to the World Health Organization, approximately 88.4 million people suffer blindness due to unaddressed refractive errors. Such rising cases of refractive errors are anticipated to propel the market's recent price in the coming years.
Breakup By End-User
Hospitals
Eye Clinics
Others
Hospitals hold the largest market share. Hospitals serve as a crucial hub for the adoption and utilization of these advanced technologies. Moreover, hospitals invest in state-of-the-art ophthalmic laser systems to offer cutting-edge treatments for various eye conditions such as cataracts, glaucoma, and refractive errors. Additionally, hospitals provide a platform for ophthalmologists and eye surgeons to perform surgeries and procedures involving ophthalmic lasers, ensuring access to comprehensive eye care for patients. The presence of these advanced technologies in hospitals contributed to improved patient outcomes, enhanced surgical precision, and expanded treatment options in the field of ophthalmology.
Breakup By Region
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America currently dominates the global market. The rise in the adoption of highly advanced techniques and systems in the manufacturing of ophthalmic lasers and the technological advancements made in ophthalmic lasers are primarily bolstering the growth of the market in the North American region. Furthermore, the rising cases of eye disorders in the region are offering lucrative growth opportunities to the market. For instance, a press release published by the Centers for Disease Control and Prevention (CDC) offered prevalence estimates for the most common eye disorders and eye diseases. Nearly 12 million adults in the United States who were 40 years and above of age had vision impairment, with about a million of them being blind. Besides this, the concerned regulatory authorities are also expediting the approval process for laser technologies, which is further creating a positive outlook for the market.
Recent News and Developments in Ophthalmic Lasers Market
January 2024: Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, announced the US launch of its next-generation platform Iridex 532 and Iridex 577 Lasers alongside its 35th-anniversary celebration.
January 2024: Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced that the US Food and Drug Administration (FDA) approved the TENEO Excimer Laser Platform for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for myopia and myopic astigmatism.
December 2023: VISTA Eye Specialist (VISTA) announced the successful introduction of CLEAR (Corneal Lenticule Extraction for Advanced Refractive Correction), an advanced version of the Lenticule Extraction treatment used to correct short-sightedness and Astigmatism, marking a significant leap for refractive surgery in Malaysia.
April 2022: Nova Eye Medical launched its next-generation canaloplasty device, iTrack Advance , in Europe and Asia-Pacific. The iTrack Advance features include a proprietary illuminated fiber optic tip of the original iTrack device to allow the surgeon to continuously monitor the location of the device in Schlemm's canal.
April 2022: Lumibird Group launched the Capsulo Nd:YAG laser . The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
